3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Pediatrics: new trials by email Literature Review of Pediatrics trials Research Report on Pediatrics
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pediatric Transcranial Static Magnetic Field Stimulation to Improve Motor Learning Transcranial Static Magnetic Field Stimulation (tSMS), Sham Transcranial Static Magnetic Field Stimulation (tSMS) - Healthy, Pediatrics | Phase 1 | Completed | University of Calgary | 24 | 2018-03-30 | 2019-08-05 |
| This is a Phase 1 Study of Eribulin Mesylate in Pediatric Participants With Recurrent or Refractory Solid Tumors (Excluding [Central Nervous System] CNS), Including Lymphomas Eribulin Mesylate - Pediatrics, Solid Tumors | Phase 1 | Completed | Eisai Inc. | 23 | 2014-07-31 | 2019-01-15 |
| Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects Rivaroxaban (Xarelto, BAY59-7939) - Venous Thrombosis, Pediatrics | Phase 1 | Completed | Bayer | 59 | 2010-11-01 | 2015-08-06 |
Lymphoma (1) · Neoplasms (1) · Venous Thrombosis (1)
Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms by Histologic Type (1) · Thrombosis (1) · Vascular Diseases (1)
Rivaroxaban (1) · eribulin (1)
Bayer (1) · Eisai Inc. (1) · University of Calgary (1)
Canada (2) · United States (2) · Australia (1) · Austria (1) · France (1) · Germany (1) · Ireland (1) · Israel (1) · Italy (1) · Switzerland (1)
PMID 23912563, PMID 30534007, PMID 30534008
2009 (1)